The Supreme Court heard arguments on Tuesday regarding a challenge to the Food and Drug Administration's (FDA) regulations on dispensing an abortion drug. The regulations, implemented since 2016, have made access to the drug mifepristone easier, including through mail-order services. This drug is used in nearly two-thirds of abortions in the United States.
A majority of the justices, including some conservatives, indicated that the plaintiffs challenging the regulations may lack the legal standing to sue and block nationwide access to the medication. This could potentially lead to the court not addressing broader legal arguments about the FDA's authority to regulate the safety of medicines.
